This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: University of Washington. Active years: 2010-2018.
Company Filing History:
Years Active: 2010-2018
Title: Wendy H. Raskind: Innovator in Ataxic Neurological Disease Research
Introduction
Wendy H. Raskind is a prominent inventor based in Seattle, WA, known for her significant contributions to the field of genetics and neurological diseases. With a focus on ataxic neurological disorders, she has developed innovative methods and kits that aid in identifying genetic predispositions to these conditions. Her work has garnered attention for its potential impact on diagnosis and treatment.
Latest Patents
Wendy H. Raskind holds 2 patents related to her research on ataxic neurological disease. Her latest patents include methods for identifying genetic mutations associated with this condition. One patent provides methods for identifying differences in nucleic acid sequences of the protein kinase C gamma gene between subjects exhibiting ataxia and those who do not. This difference is crucial for identifying genetic mutations linked to ataxic neurological disease. Additionally, her patents include isolated nucleic acid molecules encoding protein kinase C gamma missense mutations and methods for screening subjects for genetic predispositions to develop ataxic neurological diseases. Kits for determining susceptibility or presence of ataxic neurological disease in mammalian subjects are also part of her innovative contributions.
Career Highlights
Wendy H. Raskind is affiliated with the University of Washington, where she continues her research and development in the field of genetics. Her work has been instrumental in advancing the understanding of ataxic neurological diseases and their genetic underpinnings.
Collaborations
Wendy has collaborated with notable colleagues, including Dong-Hui Chen and Thomas D. Bird, enhancing the breadth and depth of her research efforts.
Conclusion
Wendy H. Raskind's innovative work in identifying genetic mutations associated with ataxic neurological diseases positions her as a key figure in the field of genetic research. Her contributions have the potential to significantly improve diagnostic methods and patient outcomes.